Skip to content

Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation

Lactate Assessment in the Treatment of Early Sepsis: The LactATES Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00372502
Acronym
LactATES
Enrollment
300
Registered
2006-09-07
Start date
2007-01-31
Completion date
2008-12-31
Last updated
2009-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock, Severe Sepsis

Keywords

sepsis, shock, emergency department, resuscitation

Brief summary

The purpose of this study is to determine if there is equivalence between two different methods of treating patients with severe bloodstream infection called sepsis. We will randomly assign patients to one of two treatment methods. One of the treatment methods is the current standard of care and uses an infrared sensor on the end of a catheter to determine the adequacy of treatment. The second treatment method is identical to the first but instead of the infrared sensor a blood test that is performed as a part of standard care (with blood drawn from the catheter) will be used to determine the adequacy of treatment. This study will attempt to determine an easier method of guiding treatment.

Interventions

PROCEDUREModified EGDT

Early goal directed therapy with lactate clearance

PROCEDUREStandard EGDT

Early goal directed therapy

Sponsors

National Institute of General Medical Sciences (NIGMS)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Suspected infection 2. Any two of four criteria of systemic inflammatory response 3. SBP \< 90 mm Hg after 20cc/kg crystalloid (septic shock) or either a whole blood lactate \> 4 mmol/L (severe sepsis).

Exclusion criteria

1. Age \< 18 years 2. Pregnancy 3. Established Do Not Resuscitate orders prior to enrollment 4. Primary diagnosis other than sepsis 5. Requirement for immediate surgery in \< 6 hours from admission 6. Any absolute contraindication to central venous catheterization

Design outcomes

Primary

MeasureTime frame
MortalityIn-hospital

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026